1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Borel F, Konstantinova P and Jansen PL:
Diagnostic and therapeutic potential of miRNA signatures in
patients with hepatocellular carcinoma. J Hepatol. 56:1371–1383.
2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Yu MC and Yuan JM: Environmental factors
and risk for hepatocellular carcinoma. Gastroenterology. 127 5
Suppl 1:S72–S78. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bi Q, Tang S, Xia L, Du R, Fan R, Gao L,
Jin J, Liang S, Chen Z, Xu G, et al: Ectopic expression of MiR-125a
inhibits the proliferation and metastasis of hepatocellular
carcinoma by targeting MMP11 and VEGF. PLoS One. 7:e401692012.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Karaman B, Battal B, Sari S and Verim S:
Hepatocellular carcinoma review: Current treatment and
evidence-based medicine. World J Gastroenterol. 20:18059–18060.
2014.PubMed/NCBI
|
7
|
Jonas S, Bechstein WO, Steinmüller T,
Herrmann M, Radke C, Berg T, Settmacher U and Neuhaus P: Vascular
invasion and histopathologic grading determine outcome after liver
transplantation for hepatocellular carcinoma in cirrhosis.
Hepatology. 33:1080–1086. 2001. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kuhn AR, Schlauch K, Lao R, Halayko AJ,
Gerthoffer WT and Singer CA: MicroRNA expression in human airway
smooth muscle cells: Role of miR-25 in regulation of airway smooth
muscle phenotype. Am J Respir Cell Mol Biol. 42:506–513. 2010.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.PubMed/NCBI
|
11
|
Kato M and Slack FJ: microRNAs: Small
molecules with big roles - C. elegans to human cancer. Biol Cell.
100:71–81. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Li XY, Feng XZ, Tang JZ, Dong K, Wang JF,
Meng CC, Wang J, Mo YW and Sun ZW: MicroRNA-200b inhibits the
proliferation of hepatocellular carcinoma by targeting DNA
methyltransferase 3a. Mol Med Rep. 13:3929–3935. 2016.PubMed/NCBI
|
15
|
Chen JS, Li HS, Huang JQ, Dong SH, Huang
ZJ, Yi W, Zhan GF, Feng JT, Sun JC and Huang XH: MicroRNA-379-5p
inhibits tumor invasion and metastasis by targeting FAK/AKT
signaling in hepatocellular carcinoma. Cancer Lett. 375:73–83.
2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Guan C, Yang F, He X, Li T, Yang Q, He H
and Xu M: Clinical significance of microRNA-155 expression in
hepatocellular carcinoma. Oncol Lett. 11:1574–1580. 2016.PubMed/NCBI
|
17
|
Chang RM, Xu JF, Fang F, Yang H and Yang
LY: MicroRNA-130b promotes proliferation and EMT-induced metastasis
via PTEN/p-AKT/HIF-1α signaling. Tumour Biol. 37:10609–10619. 2016.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Dong Y, Zou J, Su S, Huang H, Deng Y, Wang
B and Li W: MicroRNA-218 and microRNA-520a inhibit cell
proliferation by downregulating E2F2 in hepatocellular carcinoma.
Mol Med Rep. 12:1016–1022. 2015.PubMed/NCBI
|
21
|
Chen X, Bo L, Zhao X and Chen Q:
MicroRNA-133a inhibits cell proliferation, colony formation
ability, migration and invasion by targeting matrix
metallopeptidase 9 in hepatocellular carcinoma. Mol Med Rep.
11:3900–3907. 2015.PubMed/NCBI
|
22
|
Li G, Yang F, Xu H, Yue Z, Fang X and Liu
J: MicroRNA-708 is downregulated in hepatocellular carcinoma and
suppresses tumor invasion and migration. Biomed Pharmacother.
73:154–159. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Savi F, Forno I, Faversani A, Luciani A,
Caldiera S, Gatti S, Foa P, Ricca D, Bulfamante G, Vaira V and
Bosari S: miR-296/Scribble axis is deregulated in human breast
cancer and miR-296 restoration reduces tumour growth in vivo. Clin
Sci (Lond). 127:233–242. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Xu C, Li S, Chen T, Hu H, Ding C, Xu Z,
Chen J, Liu Z, Lei Z, Zhang HT, et al: miR-296-5p suppresses cell
viability by directly targeting PLK1 in non-small cell lung cancer.
Oncol Rep. 35:497–503. 2016.PubMed/NCBI
|
25
|
Lee KH, Lin FC, Hsu TI, Lin JT, Guo JH,
Tsai CH, Lee YC, Lee YC, Chen CL, Hsiao M and Lu PJ:
MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in
prostate cancer by directly targeting Pin1. Biochim Biophys Acta.
1843:2055–2066. 2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Hong L, Han Y, Zhang H, Li M, Gong T, Sun
L, Wu K, Zhao Q and Fan D: The prognostic and chemotherapeutic
value of miR-296 in esophageal squamous cell carcinoma. Ann Surg.
251:1056–1063. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li T, Lu YY, Zhao XD, Guo HQ, Liu CH, Li
H, Zhou L, Han YN, Wu KC, Nie YZ, et al: MicroRNA-296-5p increases
proliferation in gastric cancer through repression of
Caudal-related homeobox 1. Oncogene. 33:783–793. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Wei JJ, Wu X, Peng Y, Shi G, Basturk O,
Yang X, Daniels G, Osman I, Ouyang J, Hernando E, et al: Regulation
of HMGA1 expression by microRNA-296 affects prostate cancer growth
and invasion. Clin Cancer Res. 17:1297–1305. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Agarwal E, Brattain MG and Chowdhury S:
Cell survival and metastasis regulation by Akt signaling in
colorectal cancer. Cell Signal. 25:1711–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Kang B, Hao C, Wang H, Zhang J, Xing R,
Shao J, Li W, Xu N, Lu Y and Liu S: Evaluation of
hepatic-metastasis risk of colorectal cancer upon the protein
signature of PI3K/AKT pathway. J Proteome Res. 7:3507–3515. 2008.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Xu X, Sakon M, Nagano H, Hiraoka N,
Yamamoto H, Hayashi N, Dono K, Nakamori S, Umeshita K, Ito Y, et
al: Akt2 expression correlates with prognosis of human
hepatocellular carcinoma. Oncol Rep. 11:25–32. 2004.PubMed/NCBI
|
33
|
Wang L, Yao J, Sun H, Sun R, Chang S, Yang
Y, Song T and Huang C: miR-302b suppresses cell invasion and
metastasis by directly targeting AKT2 in human hepatocellular
carcinoma cells. Tumour Biol. 37:847–855. 2016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Liu LL, Lu SX, Li M, Li LZ, Fu J, Hu W,
Yang YZ, Luo RZ, Zhang CZ and Yun JP: FoxD3-regulated microRNA-137
suppresses tumour growth and metastasis in human hepatocellular
carcinoma by targeting AKT2. Oncotarget. 5:5113–5124. 2014.
View Article : Google Scholar : PubMed/NCBI
|